By Professor Sean Emery

Journal articles

Carr AD; Chuah J; Hudson J; French MA; Hoy JF; Law MG; Sayer D; Emery S; Cooper DA; On BOTC, 2000, 'A randomised, open-label comparison of three highly active antiretroviral therapy regimes including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study', AIDS, 14, pp. 1171 - 1180

Ruxrungtham K; Suwanagool S; Tavel JA; Chuenyam M; Kroon E; Ubolyam S; Buranapraditkun S; Techasathit W; Li Y; Emery S; Davey RC; Fosdick L; Kunanusont C; Lane HC; Phanuphak P; And TVSG, 2000, 'A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand', AIDS, 14, pp. 2509 - 2513

Losso MH; Belloso WH; Emery S; Benetucci JA; Cahn PE; Lasala MC; Lopardo G; Salomon H; Saracco M; Nelson E; Law MG; Davey RC; Allende MC; Lane HC; And TVSG, 2000, 'A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts ? 350/mm³', Journal of Infectious Diseases, 181, pp. 1614 - 1621

Clezy KR; Emery S, 2000, 'Clinical trials of antiretroviral therapy in developing countries', Australian and New Zealand Journal of Medicine, pp. 3 - 4

Mills J; Carr AD; Smith DE; Emery S; Law MG; Grey PA; Cooper DA, 2000, 'Lipodystrophy following antiretroviral therapy of primary HIV infection (letter)', AIDS, 14, pp. 2406 - 2407

Emery S; Capra WB; Cooper DA; Mitsuyasu RT; Kovacs JA; Vig P; Smolskis M; Saravolatz LD; Lane HC; Fyfe G; Curtin PT; For TII, 2000, 'Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease', Journal of Infectious Diseases, 182, pp. 428 - 434

Cooper DA; Emery S, 1999, 'Latent reservoirs of HIV infection: Flushing with IL-2?', Nature Medicine, pp. 611 - 612

Kelleher AD; Roggensack M; Emery S; Carr AD; French MA; Cooper DA, 1998, 'Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens', Clinical and Experimental Immunology, 113, pp. 85 - 91

Carr AD; Emery S; Lloyd AR; Hoy JF; Garsia R; French MA; Stewart GA; Fyfe G; Cooper DA, 1998, 'Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, milticenter study', Journal of Infectious Diseases, 178, pp. 992 - 999, http://jid.oxfordjournals.org/content/178/4/992.full.pdf+html

Cooper DA; Emery S, 1998, 'Therapeutic strategies for HIV infection - time to think hard. (Editorial)', New England Journal of Medicine, pp. 1319 - 1321

Emery S; Cooper DA, 1997, 'Drug companies have a duty to continue treatment', British Medical Journal: Clinical Research, pp. 889 - 889

Emery S; Lane HC, 1997, 'Immune reconstitution in HIV infection', Current Opinion in Immunology, pp. 568 - 572

Kelleher S; Emery S; Cunningham PH; Duncombe CJ; Carr AD; Golding H; Forde S; Hudson J; Roggensack M; Forrest BD; Cooper DA, 1997, 'Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injection', AIDS Research and Human Retroviruses, 13, pp. 29 - 32

Dax EM; Best SJ, 1996, 'If it's the virus why aren't we measuring it? [3]', Medical Journal of Australia, 165, pp. 119, http://dx.doi.org/10.5694/j.1326-5377.1996.tb124875.x

Emery S; Lane HC, 1996, 'Immune-based therapies in HIV infection: recent developments.', AIDS (London, England), 10 Suppl A, http://dx.doi.org/10.1097/00002030-199601001-00022

Carr AD; Emery S; Kelleher AD; Law MG; Cooper DA, 1996, 'CD8+ lymphocyte responses to antiretroviral therapy of HIV infection', Journal of acquired immune deficiency syndrome and human retrovirology, 13, pp. 320 - 326

Emery S; Lane HC, 1996, 'Immune-based therapies in HIV infection', AIDS, 10, pp. S159 - 164, http://dx.doi.org/10.1097/00002030-199601001-00022

Schooley RT; Ramirez-Ronda C; Lange JM; Cooper DA; Lavelle J; Lefkowitz L; Moore MW; Larder BA; St Clair M; Mulder JW; Mckinnis R; Pennington KN; Harrigan PR; Kinghorn I; Steel H; Rooney J, 1996, 'Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy', Journal of Infectious Diseases, 173, pp. 1354 - 1366

Emery S; Cooper DA, 1995, 'Antiretro viral therapy of human immunodeficiency virus type‐1 (HIV‐1) infection', Australian and New Zealand Journal of Medicine, 25, pp. 344 - 349, http://dx.doi.org/10.1111/j.1445-5994.1995.tb01900.x

Emery S; Carr A; Cooper DA, 1995, 'If it's the virus, why aren't we measuring it?', The Medical journal of Australia, 163, pp. 508 - 509, http://dx.doi.org/10.5694/j.1326-5377.1995.tb124712.x

Cooper DA; Gatell JM; Kroon S; Clumeck N; Millard J; Goebel FD; Bruun JN; Stingl G; Melville RL; Gonzalez-Lahoz J; Stevens JW; Fiddian AP, 1993, 'Zidovudine in Persons with Asymptomatic HIV Infection and CD4+ Cell Counts Greater than 400 per Cubic Millimeter', New England Journal of Medicine, 329, pp. 297 - 303, http://dx.doi.org/10.1056/NEJM199307293290501

Slater TF; Cheeseman KH; Benedetto C; Collins M; Emery S; Maddix SP; Nodes JT; Proudfoot K; Burton GW; Ingold KU, 1990, 'Studies on the hyperplasia ('regeneration') of the rat liver following partial hepatectomy. Changes in lipid peroxidation and general biochemical aspects', Biochemical Journal, 265, pp. 51 - 59, http://dx.doi.org/10.1042/bj2650051

Cheeseman KH; Emery S; Maddix SP; Slater TF; Burton GW; Ingold KU, 1988, 'Studies on lipid peroxidation in normal and tumour tissues. The Yoshida rat liver tumour', Biochemical Journal, 250, pp. 247 - 252, http://dx.doi.org/10.1042/bj2500247

Cheeseman KH; Davies MJ; Emery S; Maddix SP; Slater TF, 1987, 'Effects of αtocopherol on carbon tetrachloride metabolism in rat liver microsomes', Free Radical Research, 3, pp. 325 - 330, http://dx.doi.org/10.3109/10715768709069800

Emery S; Oldham HG; Norman SJ; Chenery RJ, 1985, 'The effect of cimetidine and ranitidine on paracetamol glucuronidation and sulphation in cultured rat hepatocytes', Biochemical Pharmacology, 34, pp. 1415 - 1421, http://dx.doi.org/10.1016/0006-2952(85)90678-1

Back to profile page